Duodenal GIST Responds to Surgery, Imatinib : IMNG Oncology Report
Links shared publicly online about this topic.
- 30total visits
Duodenal GIST Responds to Surgery, Imatinib : IMNG Oncology Report
The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.
View full resource at oncologyreport.com
Most Recently Shared on May 3, 2012 at 4:30 pm By:
Surgery and imatinib yield good overall survival for duodenal GIST. http://t.co/bnpryaMs
Advertisement
